Learn more about a sector with high potential
A largely untapped key sector for Montreal, the life sciences sector can boast new infrastructure in 2016, and is poised to become a global leader in the field of medical research. The business models have undergone a change and major international pharmaceutical companies are now more than ever working with SMEs and research centres, of which there are an abundance in Quebec and its metropolis. The life sciences and health technology (LSHT) sector is growing, and the industry’s contribution to the province’s GDP is comparable to that of the aerospace industry.
By taking part in this forum, you will:
- understand the economic importance of the life sciences sector for the city and for the province of Quebec
- learn more about Montreal’s strategic position as a hub for research and innovation
- explore successful strategies for growth in this and forward-looking industry
- establish contacts with the sector’s key players.
Political decision-makers, sector representatives, and businesspeople are invited to attend this forum that will shed some light on this industry’s important contribution to the city.
The life sciences and health technology (LSHT) industry in the Greater Montreal area:
- is made up of 600 organizations, including 150 research centres and 80 subsidiaries of world-class foreign companies
- includes 40,000 jobs, putting it in 7th place in North America in terms of employment concentration
- has the most competitive operating costs among major North American cities.
Source: Montréal InVivo, 2016
Do not miss this event which will take place in the presence of:
For the program, click here.
Program:
Opening Remarks
Minister’s Speech
Part I – The LSHT industry: an instrument of prosperity for québec and its metropolis
Québec and its metropolis: world-class players
Prospering in a new business environment
Commercialization of innovation: a major challenge
For a better integration of innovation in the health system
Part II – Focusing on our pillars to speed up growth in the LSHT industry
Montreal: center of research and innovation
Funding to maximize R&D spin-offs
-
Didier LeconteSenior Director, Investments, Life Sciences Sector
Fonds de solidarité FTQ
-
Louise Proulx, PhD.Venture Partner
Sanderling
-
Pierre FalardeauPresident and CEO
Verlyx Pharma
Consolidating partnerships: building bridges between research and industry needs
-
Philippe WalkerChief Scientific Officer
NÉOMED
-
Diane CôtéPresident and CEO
MEDTEQ
-
Nadine BeaugerChief Executive Officer
IRIC - commercialisation de la recherche
-
Claude ChevalierFounder and Chairman of the Board
Bio-K+
Part III – Future prospects and opportunities to be seized
Promoting the attractiveness and competitiveness of the LSHT sector internationally
-
Christelle FasanoDirector, Business Development, Life Sciences and health technology
Montréal International
-
Patrick HupéMedtronic du Canada
The emergence of genomics and specialized medicine: a revolution that is creating business opportunities
-
Martin LeblancPresident and CEO
Caprion Biosciences
Presentation
The big data applied to innovation in LSHT
-
Yoshua BengioProfesseur titulaire, Département d'informatique et de recherche opérationnelle,
Chaire de Recherche du Canada sur les algorithmes d'apprentissage statistique
IVADO
Presentation